RhumbLine Advisers’s Nobilis Health Corp. HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-49,207
Closed -$84K 2986
2017
Q1
$84K Buy
49,207
+2,597
+6% +$5.4K ﹤0.01% 2793
2016
Q4
$98K Sell
46,610
-3,187
-6% -$8.67K ﹤0.01% 2795
2016
Q3
$167K Buy
49,797
+4,800
+11% +$14.4K ﹤0.01% 2734
2016
Q2
$100K Buy
44,997
+21,135
+89% +$68.6K ﹤0.01% 2915
2016
Q1
$74K Hold
23,862
﹤0.01% 2932
2015
Q4
$67K Buy
23,862
+4,600
+24% +$14.7K ﹤0.01% 2985
2015
Q3
$101K Buy
19,262
+1,132
+6% +$6.5K ﹤0.01% 2943
2015
Q2
$123K Buy
+18,130
New +$129K ﹤0.01% 2986

Other funds holding HLTH

RhumbLine Advisers's HLTH Position: Q2 2017 in Review

RhumbLine Advisers sold out of Nobilis Health Corp. (HLTH) in Q2 2017, closing a stake of 49,207 shares — an estimated $84K sold.

RhumbLine Advisers first reported a position in HLTH in Q2 2015 and held it in 8 quarters. The position peaked at $167K in Q3 2016. 49 funds tracked by Wall St. Rank hold HLTH as of Q2 2017.

  • RhumbLine Advisers reported no remaining Nobilis Health Corp. position as of Q2 2017 after selling out during the quarter.
  • RhumbLine Advisers sold 49,207 Nobilis Health Corp. shares in Q2 2017, an estimated $84K.
  • RhumbLine Advisers first reported a position in Nobilis Health Corp. in Q2 2015 and held it in 8 quarters.
  • RhumbLine Advisers's Nobilis Health Corp. position peaked at $167K in Q3 2016.
  • 49 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q2 2017.

Based on RhumbLine Advisers's 13F filing for Q2 2017, filed 2 Aug 2017.